Lipoprotein-associated phospholipase A2 activity is a marker of risk but not a useful target for treatment in patients with stable coronary heart disease
Wallentin, Lars
;
Held, Claes
;
Armstrong, Paul W.
;
Cannon, Christopher Paul
;
Davies, Richard Y.
;
Granger, Christopher B.
;
Hagström, Emil
;
Harrington, Robert A.
;
Viigimaa, Margus
Journal of the American Heart Association
2016
/
art. e003407
https://doi.org/10.1161/JAHA.116.003407
https://www.scopus.com/sourceid/21100246515
https://www.scopus.com/record/display.uri?eid=2-s2.0-84991521940&origin=resultslist&sort=plf-f&src=s&sid=0d4103ec4066ce838efe26af30d79d49&sot=b&sdt=b&s=DOI%2810.1161%2FJAHA.116.003407%29&sl=28&sessionSearchId=0d4103ec4066ce838efe26af30d79d49&relpos=0
https://jcr.clarivate.com/jcr-jp/journal-profile?journal=J%20AM%20HEART%20ASSOC&year=2016
https://www.webofscience.com/wos/woscc/full-record/WOS:000386712700045